Cyclophosphamide in the treatment of toxic epidermal necrolysis

Nikolaos G. Frangogiannis, Illya Boridy, Mobeen Mazhar, Rajy Mathews, Subroto Gangopadhyay, Thomas Cate

Research output: Contribution to journalArticlepeer-review

59 Scopus citations


A patient with non-small cell lung carcinoma and recent radiotherapy for brain metastases developed toxic epidermal necrolysis (TEN) shortly after therapy with phenytoin was initiated for a seizure. Exfoliation progressed to involve 90% of her body surface despite treatment with high-dose corticosteroids for 5 days, but sloughing and systemic toxicity ceased within 2 days of initiating therapy with intravenous cyclophosphamide (300 mg/day). Reepithelialization rapidly followed. This experience and the reports of others suggest that intravenous cyclophosphamide is helpful in the treatment of TEN.

Original languageEnglish (US)
Pages (from-to)1001-1003
Number of pages3
JournalSouthern Medical Journal
Issue number10
StatePublished - Oct 29 1996
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Cyclophosphamide in the treatment of toxic epidermal necrolysis'. Together they form a unique fingerprint.

Cite this